A study of soluble CD30 in patients with primary immune thrombocytopenia

Estimation of plasma sCD30 and CD30 mRNA levels has good utility for assessing the disease activity in patients with ITP.

Authors

Institutions

Publication Details

Journal
Laboratory Medicine
Published
2025-04-19
DOI
https://doi.org/10.1093/labmed/lmaf020
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A study of soluble CD30 in patients with primary immune thrombocytopenia

Ehsan Rizk, Yasser Mahmoud Ismail, Aliaa M. Diab, Seham Gouda Ameen et al.
Laboratory Medicine
Platelet Disorders and Treatments
article

A study of soluble CD30 in patients with primary immune thrombocytopenia

Ehsan Rizk, Yasser Mahmoud Ismail, Aliaa M. Diab, Seham Gouda Ameen, Amira M N Abdelrahman
article en

Abstract

Estimation of plasma sCD30 and CD30 mRNA levels has good utility for assessing the disease activity in patients with ITP.

Laboratory MedicineVol. 56(6)
Benha University (EG)
Good health and well-being
Openalex Percentile: Top 83%
Platelet Disorders and Treatments
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A study of soluble CD30 in patients with primary immune thrombocytopenia — Ehsan Rizk, Yasser Mahmoud Ismail, et al. · Laboratory Medicine (2025) | TGRS Research Map | TGRS